<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01119690</url>
  </required_header>
  <id_info>
    <org_study_id>KHMetS-03-AP</org_study_id>
    <secondary_id>HMS-03</secondary_id>
    <nct_id>NCT01119690</nct_id>
  </id_info>
  <brief_title>Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function</brief_title>
  <acronym>HMS-03</acronym>
  <official_title>Hämeenlinna Metabolic Syndrome Research Program (HMS): Effects of Dietary Cold-pressed Turnip Rapeseed Oil and Milk Fat on Serum Lipids, Oxidized LDL, Arterial Elasticity and Platelet Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital of Kanta-Hame</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Linnan Klinikka Oy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MTT Agrifood Research Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finnish Red Cross</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital of Kanta-Hame</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the effects of dietary intake of cold-pressed turnip rapeseed oil (CTPRO) and
      milk fat are compared in men with metabolic syndrome having already participated in HMS-02
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This open and balanced cross-over study consists of two dietary treatment phases (either
      Virgino (R) CTPRO or butter) for 6 to 8 weeks. They are separated from each other with an
      eight-week washout period. At the end of both periods and 12-hour fasting an oral glucose-fat
      tolerance test is carried out. Except glucose, the test consists cream (after the butter
      phase) and CTPRO (after the CTPRO phase).

      Otherwise, the subjects (n=43) are asked to maintain their normal dietary habits.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2004</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">April 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Circulating lipids</measure>
    <time_frame>6 to 8 weeks</time_frame>
    <description>At the end of both 6- to 8-week dietary periods, fasting values of circulating lipids including oxidized LDL are determined</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet function</measure>
    <time_frame>6 to 8 weeks</time_frame>
    <description>At the end of both 6- to 8-week dietary periods, platelet function is determined</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose tolerance</measure>
    <time_frame>5 hours</time_frame>
    <description>During a 5-hour oral glucose-fat tolerance test the area under curve of plasma glucose and insulin concentration is determined</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial elasticity</measure>
    <time_frame>6 to 8 weeks</time_frame>
    <description>At the end of both 6- to 8-week dietary periods, arterial elasticity is determined</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum triglyceride AUC</measure>
    <time_frame>5 hours</time_frame>
    <description>During a 5-hour oral glucose-fat tolerance test the area under curve of serum triglyceride concentration is determined</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet function</measure>
    <time_frame>5 hours</time_frame>
    <description>During a 5-hour oral glucose-fat tolerance test the platelet function is determined</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Rapeseed oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Milk fat</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cold-pressed turnip rapeseed oil (CTPRO)</intervention_name>
    <description>In the dietary period of 6 to 8 weeks: CTPRO 37 ml/day.
In the 5-hour oral glucose and fat tolerance test: glucose and CTPRO.</description>
    <arm_group_label>Rapeseed oil</arm_group_label>
    <other_name>Virgino</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>milk fat</intervention_name>
    <description>In dietary period of 6 to 8 weeks: 37.5 grams of butter.
In the 5-hour oral glucose and fat tolerance test: glucose and cream</description>
    <arm_group_label>Milk fat</arm_group_label>
    <other_name>Valio butter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  43 men with metabolic syndrome having already participated in the HMS-02 Study

          -  Willing to participate in a demanding dietary study

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>31 Years</minimum_age>
    <maximum_age>66 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ari K Palomäki, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Central Hospital of Kanta-Häme</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kalevi Oksanen, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Central Hospital of Kanta-Häme</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Finnish Red Cross Blood Transfusion Service</name>
      <address>
        <city>Helsinki</city>
        <zip>00310</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Linnan Klinikka</name>
      <address>
        <city>Hämeenlinna</city>
        <zip>13100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Hospital of Kanta-Häme</name>
      <address>
        <city>Hämeenlinna</city>
        <zip>13530</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MTT Agrifood Research Finland</name>
      <address>
        <city>Jokioinen</city>
        <zip>31600</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2010</study_first_submitted>
  <study_first_submitted_qc>May 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2010</study_first_posted>
  <last_update_submitted>May 6, 2010</last_update_submitted>
  <last_update_submitted_qc>May 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Ari Palomäki, MD PhD, Head of department</name_title>
    <organization>Central Hospital of Kanta-Häme</organization>
  </responsible_party>
  <keyword>Dietary</keyword>
  <keyword>Cross-Over Study</keyword>
  <keyword>Lipids</keyword>
  <keyword>Rapeseed oil</keyword>
  <keyword>Butter</keyword>
  <keyword>Milk Fat</keyword>
  <keyword>Unsaturated Fat</keyword>
  <keyword>Saturated Fat</keyword>
  <keyword>Oxidized LDL</keyword>
  <keyword>Platelet Function</keyword>
  <keyword>Arterial Elasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

